Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells - Concepedia

Concepedia

Publication | Closed Access

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells

25

Citations

38

References

2023

Year

Alessia Potenza, Chiara Balestrieri, Martina Spiga, Luca Albarello, Federica Pedica, Francesco Manfredi, Beatrice Claudia Cianciotti, Claudia de Lalla, Oronza A. Botrugno, Cristina Faccani,

Abstract

HER-2-specific CD39 disrupted engineered T cells are promising advanced medicinal products for primary and metastatic CRC.

References

	Year	Citations

Page 1